TSX:CURA - Post Discussion
Post by
blackspade799 on Nov 27, 2024 9:45am
FDA gives green light to PTSD marijuana study
The Food and Drug Administration (FDA) this week authorized a long-delayed clinical trial to test whether smoking marijuana can be used to treat post-traumatic stress disorder (PTSD) in veterans.
The trial, sponsored by the nonprofit Multidisciplinary Association for Psychedelic Studies (MAPS), has been blocked by the FDA since 2021. The agency had raised a variety of objections, including that allowing people to inhale high-potency cannabis was dangerous to their health.
The FDA also objected to the study’s “self-titration” dosing method, which will allow participants to smoke as much cannabis as they feel they need to relieve their symptoms up to a daily limit.
But on Wednesday, MAPS announced that the FDA will allow the trial to proceed. Importantly, they said the FDA no longer objects to either smoking or letting participants choose their preferred amount.
https://www.aol.com/fda-gives-green-light-ptsd-231111607.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr
Be the first to comment on this post